Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig's disease, is an incurable neurological disorder affecting motor ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

Nucleus Network, a global leader in early phase clinical research, today announced the acquisition of Hammersmith Medicines Research (HMR), one of the United Kingdom’s most respected early phase ...

In a first for type 1 diabetes, researchers have gene-edited donor pancreatic islets in a way that evades the immune system to enable insulin secretion for at least 6 months.

More states are passing laws to protect information generated by a person's brain and nervous system as technology improves ...

Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig's disease, is an incurable neurological disorder affecting motor ...

Nucleus Network acquires UK-based clinical trial organisation, Hammersmith Medicines Research: Brisbane, Australia Tuesday, August 5, 2025, 14:00 Hrs [IST] Nucleus Network, a glob ...

CLEVELAND— Amyotrophic lateral sclerosis (ALS ), known as Lou Gehrig's disease, is an incurable neurological disorder affecting motor neurons—nerve ...

Deputy premier says the state has now conducted eight such trials, and that of the 25 new oncology drugs developed and ...

When Frank Poulsen, 72, first started talking to artificial intelligence companion Sunny earlier this year, she was “kind of ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...

The FDA is expected to decide on treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy.